세계의 박막 의약품 제조 시장 : 예측(2025-2030년)

The thin film drug manufacturing market is estimated at US$7.391 billion in 2025 and is anticipated to grow at a CAGR of 6.45% during the forecast period and reach US$10.102 billion in 2030.

Thin film drug manufacturing is an emerging sector within the pharmaceutical industry that focuses on developing innovative drug delivery systems. Thin films are flexible layers containing active pharmaceutical ingredients (APIs) designed for various administration routes, including oral, sublingual, buccal, or transdermal. These films dissolve or disintegrate quickly, offering a fast-acting and convenient alternative to traditional tablets and capsules. This technology has gained traction due to its ease of use, particularly for pediatric and geriatric patients who may struggle with swallowing conventional dosage forms.

Drivers of the Thin Film Drug Manufacturing Market:

• Innovations in Non-Invasive Drug Development: Advances in drug formulation technologies and the rising demand for non-invasive drug delivery methods are driving market growth. Thin film drug delivery systems have therapeutic applications in pain management, neurological disorders, and respiratory conditions. Additionally, the increasing prevalence of chronic diseases and the need for personalized medicine further bolster the adoption of these systems.

Major players in the market are investing heavily in research and development to enhance film formulations and broaden their product offerings. The focus on patient-centric drug design, which promises better bioavailability and rapid onset of action, positions thin film drug delivery as a promising area for innovation. As regulatory approvals for these products increase, the market is expected to experience significant growth in the coming years.

Geographical Outlook of the Thin Film Drug Manufacturing Market:

• North America Expected to Dominate the Market: North America is projected to hold a significant share of the thin film drug manufacturing market during the forecast period. The region's growth can be attributed to rapid advancements in thin film technologies, increased adoption of electric pumps, a well-developed healthcare infrastructure, and continuous product innovations by leading market players. These factors contribute to a robust consumer base and steady market development.

In addition, Europe is anticipated to grow at a notable rate during this period, driven by a rising population of working women and increasing demand for technologically advanced breast pumps. Companies' awareness campaigns promoting the benefits of wearable breast pumps significantly enhance market penetration. Favorable regulations and consumer preferences for innovative healthcare devices will also likely propel market growth in Europe.In summary, the thin film drug manufacturing market is set for substantial growth driven by innovations in drug delivery technologies, rising demand for non-invasive treatment options, increasing prevalence of chronic diseases, supportive regulatory environments, and significant geographical developments-especially within North America-that enhance this expanding market landscape.

Reasons for buying this report:-

• Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, other sub- segments.
• Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
• Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape up future market developments.
• Actionable Recommendations: Utilize the insights to exercise strategic decision to uncover new business streams and revenues in a dynamic environment.
• Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

• Historical data & forecasts from 2022 to 2030
• Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, Customer Behaviour, and Trend Analysis
• Competitive Positioning, Strategies, and Market Share Analysis
• Revenue Growth and Forecast Assessment of segments and regions including countries
• Company Profiling (Strategies, Products, Financial Information, and Key Developments among others)

Thin Film Drug Manufacturing Market has been segmented as following:

By Product Type:

• Oral Thin Films
• Transdermal Thin Films
• Others

By Disease Type:

• Schizophrenia
• Migraine
• Opioid Dependence
• Others

By Distribution Channel:

• Hospital Pharmacy
• Retail Pharmacy
• Others

By Geography:

• North America
• USA
• Canada
• Mexico
• South America
• Brazil
• Argentina
• Others
• Europe
• UK
• Germany
• France
• Italy
• Others
• Middle East and Africa
• Saudi Arabia
• Israel
• Others
• Asia Pacific
• Japan
• China
• India
• South Korea
• Indonesia
• Thailand
• Others

TABLE OF CONTENTS

1. INTRODUCTION

• 1.1. Market Overview
• 1.2. Market Definition
• 1.3. Scope of the Study
• 1.4. Market Segmentation
• 1.5. Currency
• 1.6. Assumptions
• 1.7. Base and Forecast Years Timeline
• 1.8. Key Benefits for the Stakeholders

2. RESEARCH METHODOLOGY

• 2.1. Research Design
• 2.2. Research Process

3. EXECUTIVE SUMMARY

• 3.1. Key Findings
• 3.2. Analyst View

4. MARKET DYNAMICS

• 4.1. Market Drivers
• 4.2. Market Restraints
• 4.3. Porter's Five Forces Analysis
  • 4.3.1. Bargaining Power of Supplier
  • 4.3.2. Bargaining Power of Buyers
  • 4.3.3. The Threat of New Entrants
  • 4.3.4. Threat of Substitutes
  • 4.3.5. Competitive Rivalry in the Industry
• 4.4. Industry Value Chain Analysis

5. THIN FILM DRUG MANUFACTURING MARKET BY PRODUCT TYPE

• 5.1. Introduction
• 5.2. Oral Thin Films
• 5.3. Transdermal Thin Films
• 5.4. Others

6. THIN FILM DRUG MANUFACTURING MARKET BY DISEASE TYPE

• 6.1. Introduction
• 6.2. Schizophrenia
• 6.3. Migraine
• 6.4. Opioid Dependence
• 6.5. Others

7. THIN FILM DRUG MANUFACTURING MARKET BY DISTRIBUTION CHANNEL

• 7.1. Introduction
• 7.2. Hospital Pharmacy
• 7.3. Retail Pharmacy
• 7.4. Others

8. THIN FILM DRUG MANUFACTURING MARKET BY GEOGRAPHY

• 8.1. Introduction
• 8.2. North America
  • 8.2.1. USA
  • 8.2.2. Canada
  • 8.2.3. Mexico
• 8.3. South America
  • 8.3.1. Brazil
  • 8.3.2. Argentina
  • 8.3.3. Others
• 8.4. Europe
  • 8.4.1. UK
  • 8.4.2. Germany
  • 8.4.3. France
  • 8.4.4. Italy
  • 8.4.5. Others
• 8.5. Middle East and Africa
  • 8.5.1. Saudi Arabia
  • 8.5.2. Israel
  • 8.5.3. Others
• 8.6. Asia Pacific
  • 8.6.1. Japan
  • 8.6.2. China
  • 8.6.3. India
  • 8.6.4. South Korea
  • 8.6.5. Indonesia
  • 8.6.6. Thailand
  • 8.6.7. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

• 9.1. Major Players and Strategy Analysis
• 9.2. Market Share Analysis
• 9.3. Mergers, Acquisitions, Agreements, and Collaborations
• 9.4. Competitive Dashboard

10. COMPANY PROFILES

• 10.1. Pfizer
• 10.2. Novartis
• 10.3. ZIM LABORATORIES LIMITED
• 10.4. IntelGenx Corp.
• 10.5. AbbVie Inc.
• 10.6. Roche
• 10.7. Nova Thin Film Pharmaceuticals LLC
• 10.8. ARx, LLC.
• 10.9. LN LABORATORIES
• 10.10. Nissha Co., Ltd.